title: Psychopharmacological treatments in HIV patients under antiretroviral therapy.
abstract: Human immunodeficiency virus-infected patients have high rates of psychiatric disorders, including substance and alcohol abuse. Prompt identification and effective management of mental disorders can improve the quality of life and antiretroviral adherence in HIV patients. Additive side effects and drug interactions may complicate the psychopharmacological treatment in this population. This article reviews the indications and precautions needed when prescribing psychoactive drugs to HIV patients with mental disorders.
authors.affiliation: Institute of Psychiatry and Mental Health, Hospital Clínico San Carlos, Department de Psychiatry, School of Medicine, Universidad Complutense, CIBERSAM (Centro para la Investigación Biomédica en Red en Salud Mental), Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain. luc.gallego@gmail.com
authors.forename: Lucía
authors.initials: L
authors.lastname: Gallego
authors.forename: Pablo
authors.initials: P
authors.lastname: Barreiro
authors.forename: Juan J
authors.initials: JJ
authors.lastname: López-Ibor
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001007:Anxiety / Q000188:drug therapy* / Q000517:prevention & control; D003863:Depression / Q000188:drug therapy* / Q000517:prevention & control; D004334:Drug Administration Schedule; D004347:Drug Interactions; D005260:Female; D017408:Guidelines as Topic; D006679:HIV Seropositivity / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D008297:Male; D055118:Medication Adherence; D011619:Psychotropic Drugs / Q000008:administration & dosage* / Q000009:adverse effects*; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000517:prevention & control
chemical_list: D019380:Anti-HIV Agents; D011619:Psychotropic Drugs